Advertisement CytoCore Signs Distribution Agreement With Synermed - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CytoCore Signs Distribution Agreement With Synermed

CytoCore Inc. (CytoCore), a in vitro diagnostics company, has signed distribution agreement with Synermed Select Partners, Inc. (Synermed) for its SoftPAP cell collector, the sample collection device. The SoftPAP Cervical Cell Collector offers specimen collection for the Pap test with minimal possibility of user errors. It is designed to consistently sample the entire cervix in a single-step using an inflatable balloon collector.

Robert McCullough, chief executive officer (CEO) of CytoCore, commented, “This agreement with Synermed allows CytoCore to offer physicians and laboratories the Synermed Preservative with our SoftPAP® cervical cell collector in one convenient, cost-effective package. The world is adopting the superior liquid-based thin-layer slide preparation technology and moving away from the PAP smear technique. Synermed’s products and technology include a cost effective migration path for the production of highest quality monolayer slides starting with a simple manual process that migrates seamlessly to highly automated slide preparation equipment as volumes increase. We believe the combination of SoftPAP and the Synermed products provide tremendous benefit to women patients, doctors and diagnostic laboratories. We are excited about introducing “the combination kit” internationally where both products are approved.”

“Synermed and its affiliate CellSolutions, LLC is dedicated to the development and delivery of improved unique cervical cancer detection products. We look forward to supplying the Synermed Cytology Preservative to CytoCore and are encouraged that there may well be other future collaborations involving CytoCore and Synermed,” stated Ernest A. Knesel, president and CEO of Synermed Select Partners and chairman of CellSolutions. Mr. Knesel was formerly CEO and founder of Tripath Inc., now a division of Becton Dickinson Inc. While at Tripath Mr. Knesel was responsible for the development of “SurePath,” their market leading liquid cell preparation product for cervical cytology testing. Unlike the liquid-based thin-layer slide preparation liquid products which dominate the market, Synermed offers both a low entry cost manual method and high volume slide preparation automation. Both the manual method and the high volume automation options use less expensive consumable supplies putting liquid-based thin-layer slide preparation within the reach of small and high volume laboratories alike, in Europe and other countries throughout the world.